Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Disaster and Emergency Medicine Journal
MENU
Shortcuts Submit an article Author Guidelines Reviewers 2023 Focus and Scope

open access

Vol 7, No 4 (2022)
Research paper
Published online: 2022-12-21
View PDF Download PDF file
Get Citation

Tranexamic acid in polish pre-hospital emergency medicine and the competencies of medical rescue teams

Pawel Jastrzebski1, Szymon Kosiorek2, Zbigniew Adamiak3, Jadwiga Snarska1
DOI: 10.5603/DEMJ.a2022.0040
·
Disaster Emerg Med J 2022;7(4):231-238.
Affiliations
  1. Shool of Public Health, University of Warmia and Mazury in Olsztyn, Poland
  2. Paramedic of Warmia and Mazury, Olsztyn, Poland
  3. Small Animal Clinic, Bialystok, Poland

open access

Vol 7, No 4 (2022)
ORIGINAL ARTICLES
Published online: 2022-12-21

Abstract

INTRODUCTION: Medical rescue teams (MRTs) are the basic components of the Polish Emergency Medicine System (PEMS) that provide pre-hospital emergency medical services. However, despite the possibility for paramedics to use 47 drugs and many complicated medical procedures, tranexamic acid was not found there. Efficacy of pre-hospital emergency medical services could be improved by using tranexamic acid (TXA) in the management of traumatic hemorrhage and traumatic brain injury (TBI). The aim of this study was to demonstrate that the competencies of MRTs should be expanded and that Polish paramedics should be authorized to independently administer TXA to TBI patients.

MATERIAL AND METHODS: The main research method was an analysis of the literature, including studies focusing on TXA administration and the associated risks. The article was written in the last two years.

RESULTS: The study demonstrated that TXA contributes to the effective management of selected types of hemorrhage and TBI and that the risk of adverse effects associated with TXA administration is minimal.

CONCLUSIONS: The gathered evidence suggests that paramedics should be authorized to independently administer TXA in pre-hospital care to maximize the efficacy of emergency medical services provided to patients in the PEMS.

Abstract

INTRODUCTION: Medical rescue teams (MRTs) are the basic components of the Polish Emergency Medicine System (PEMS) that provide pre-hospital emergency medical services. However, despite the possibility for paramedics to use 47 drugs and many complicated medical procedures, tranexamic acid was not found there. Efficacy of pre-hospital emergency medical services could be improved by using tranexamic acid (TXA) in the management of traumatic hemorrhage and traumatic brain injury (TBI). The aim of this study was to demonstrate that the competencies of MRTs should be expanded and that Polish paramedics should be authorized to independently administer TXA to TBI patients.

MATERIAL AND METHODS: The main research method was an analysis of the literature, including studies focusing on TXA administration and the associated risks. The article was written in the last two years.

RESULTS: The study demonstrated that TXA contributes to the effective management of selected types of hemorrhage and TBI and that the risk of adverse effects associated with TXA administration is minimal.

CONCLUSIONS: The gathered evidence suggests that paramedics should be authorized to independently administer TXA in pre-hospital care to maximize the efficacy of emergency medical services provided to patients in the PEMS.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

tranexamic acid; hemorrhage; system; ambulance

About this article
Title

Tranexamic acid in polish pre-hospital emergency medicine and the competencies of medical rescue teams

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 7, No 4 (2022)

Article type

Research paper

Pages

231-238

Published online

2022-12-21

Page views

3385

Article views/downloads

559

DOI

10.5603/DEMJ.a2022.0040

Bibliographic record

Disaster Emerg Med J 2022;7(4):231-238.

Keywords

tranexamic acid
hemorrhage
system
ambulance

Authors

Pawel Jastrzebski
Szymon Kosiorek
Zbigniew Adamiak
Jadwiga Snarska

References (42)
  1. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled triall. Lancet. 2017; 389(10084): 2105–2116.
    CrossRefPubMed
  2. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734): 23–32.
    CrossRefPubMed
  3. The CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019; 394(10210): 1713–1723.
    CrossRefPubMed
  4. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012; 147(2): 113–119.
    CrossRefPubMed
  5. HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled triall. Lancet. 2020; 20(395): 1927–1936.
    CrossRefPubMed
  6. Stępka A, Podlasin A, Jaskuła J, et al. and Janiszewski W. Staza taktyczna — lokalizacja w ratownictwie cywilnym. Na Ratunek. 2018; 4: 31–34.
  7. Act of 8 September 2006 on the Polish Emergency Medicine System (Journal of Laws, 2006, No. 191, item 1410). https://oipip.walbrzych.pl/pliki/prawo/ustawa%20o%20ratownictwie.pdf (14.12.2021).
  8. Pomoc doraźna i ratownictwo medyczne w 2020r. Główny Urząd Statystyczny, 2021. https://stat.gov.pl/files/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/14/5/1/pomoc_dorazna_i_ratownictwo_medyczne_w_2020_roku.pdf (20.12.2021).
  9. Zdrowie i ochrona zdrowia w 2016 r. Główny Urząd Statystyczny, 2017. https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/1/7/1/zdrowie_i_ochrona_zdrowia_w_2016.pdf (14.12.2021).
  10. Pomoc doraźna i ratownictwo medyczne w 2017 r. Główny Urząd Statystyczny, 2018. https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/14/2/1/pomoc_dorazna_i_ratownictwo_medyczne_w_2017_r.pdf (14.12.2021).
  11. Pomoc doraźna i ratownictwo medyczne w 2018 r. Główny Urząd Statystyczny, 2019. https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/14/3/1/pomoc_dorazna_i_ratownictwo_medyczne_w_2018_r.pdf (14.12.2021).
  12. Pomoc doraźna i ratownictwo medyczne w 2019 r. Główny Urząd Statystyczny, 2020. https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5513/14/4/1/pomoc_dorazna_i_ratownictwo_medyczne_w_2019_r.pdf (14.12.2021).
  13. Regulation of the Minister of Health of 16 December 2019 on emergency medical procedures and healthcare services other than emergency medical procedures that can be performed by paramedics (Journal of Laws, 2019, item 2478). https://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20190002478/O/D20192478.pdf (14.12.2021).
  14. Franchini M, Mannucci PM. The never ending success story of tranexamic acid in acquired bleeding. Haematologica. 2020; 105(5): 1201–1205.
    CrossRefPubMed
  15. Reed R, Woolley T. Uses of tranexamic acid. Continuing Edu Anaesthesia Critical Care & Pain. 2015; 15(1): 32–37.
    CrossRef
  16. Charakterystyka produktu leczniczego Exacyl 100mg/ml, roztwór do wstrzykiwań. https://leki.urpl.gov.pl/files/EXACYL_roztwdowstrzyk_100mgml.pdf (18.12.2021).
  17. Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018; 391(10116): 125–132.
    CrossRefPubMed
  18. Chen H, Chen M. The efficacy of tranexamic acid for brain injury: A meta-analysis of randomized controlled trials. Am J Emerg Med. 2020; 38(2): 364–370.
    CrossRefPubMed
  19. Stansfield R, Morris D, Jesulola E. The use of tranexamic acid (TXA) for the management of hemorrhage in trauma patients in the prehospital environment: literature review and descriptive analysis of principal themes. Shock. 2020; 53(3): 277–283.
    CrossRefPubMed
  20. Wojskowe centrum kształcenia medycznego. Taktyczna pomoc poszkodowanym na polu walki (TCCC). Wytyczne dla personelu medycznego z 5 listopada 2020 r, 2021. https://wckmed.wp.mil.pl/u/wytyczne_TCCC_2020_wersja_1.0.3_PL_docx.pdf (18.12.2018).
  21. Woroń J. Błędy w leczeniu przeciwzakrzepowym – czyli 7 grzechów głównych stosowania leków przeciwzakrzepowych, przeciwpłytkowych oraz przeciwkrwotocznych w praktyce lekarskiej. Anestezjologia i Ratownictwo. 2017; 11(2): 211–221.
  22. Lott C, Truhlář A, Alfonzo A, et al. European resuscitation council guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021; 161: 152–219.
    CrossRefPubMed
  23. Opieka przedszpitalna nad pacjentem po urazie. Omówienie aktualizacji zaleceń PHTLS 2019, Medycyna Praktyczna, 2019. https://www.mp.pl/ratownictwo/wytyczne/210465,opieka-przedszpitalna-nad-pacjentem-po-urazie-omowienie-aktualizacji-zalecen-phtls-2019 (18.12.2021).
  24. Guerriero C, Cairns J, Perel P, et al. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011; 6(5): e18987.
    CrossRefPubMed
  25. Roberts I, Yates D, Sandercock P, et al. CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004; 364(9442): 1321–1328.
    CrossRefPubMed
  26. International Trauma Life Support. Role of TXA in management of traumatic haemorrhage in the field. https://www.itrauma.org/wp-content/uploads/2020/01/Current-Thinking-TXA-Resource-Document-Update-FINAL-November-2019.pdf (14.12.2021).
  27. AEMT. TCCC Guidelines for Medical Personnel, 2017. https://www.naemt.org/docs/default-source/education-documents/tccc/tccc-updates_092017/tccc-mp-curriculum-1708/00-tccc-mp-guidelines/tccc-guidelines-for-medical-personnel-170131.pdf?sfvrsn=2&fbclid=IwAR2dzFxxY4_l-YwBfzsD0i_iPJBy4fmZ_jO0buCMTtNf2OUVUU2uDMj0O1o (14.12.2021).
  28. NAEMT. TCCC Guidelines for Medical Personnel, 2018. https://www.naemt.org/docs/default-source/education-documents/tccc/tccc-mp/guidelines/tccc-guidelines-for-medical-personnel-180801.pdf?sfvrsn=13fc892_2&fbclid=IwAR3yCm9arQF-NgkydBEof-p0WqjvmfDIiOkAKIrGwOidZaeh3teJsPJjBLA (18.12.2021).
  29. Sprigg N, Flaherty K, Appleton J, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018; 391(10135): 2107–2115.
    CrossRefPubMed
  30. Post R, Germans MR, Tjerkstra MA, et al. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021; 9(397): 112–118.
    CrossRefPubMed
  31. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2015; 16(6): CD007872.
    CrossRefPubMed
  32. Alam A, Choi S. Prophylactic use of tranexamic acid for postpartum bleeding outcomes: a systematic review and meta-analysis of randomized controlled trials. Transfus Med Rev. 2015; 29(4): 231–241.
    CrossRefPubMed
  33. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. EXADELI Study Group. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011; 15(2): R117.
    CrossRefPubMed
  34. Franchini M, Mengoli C, Cruciani M, et al. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018; 16(4): 329–337.
    CrossRefPubMed
  35. Wand O, Guber E, Guber A, et al. Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial. Chest. 2018; 154(6): 1379–1384.
    CrossRefPubMed
  36. Zahed R, Mousavi Jazayeri MH, Naderi A, et al. Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs: randomized controlled trial. Acad Emerg Med. 2018; 25(3): 261–266.
    CrossRefPubMed
  37. Beno S, Ackery AD, Callum J, et al. Tranexamic acid in pediatric trauma: why not? Crit Care. 2014; 18(4): 313.
    CrossRefPubMed
  38. Eckert MJ, Wertin TM, Tyner SD, et al. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma Acute Care Surg. 2014; 77(6): 852–8; discussion 858.
    CrossRefPubMed
  39. Van de Voorde P, Turner NM, Djakow J, et al. European Resuscitation Council Guidelines 2021: Paediatric Life Support. Resuscitation. 2021; 161: 327–387.
    CrossRefPubMed
  40. Maconochie IK, Bingham R, Eich C, et al. Paediatric life support section Collaborators. European Resuscitation Council Guidelines for Resuscitation 2015: Section 6. Paediatric life support. Resuscitation. 2015; 95: 223–248.
    CrossRefPubMed
  41. Justin Morgenstern, "CRASH 3: TXA is no wonder drug", First10EM blog, October 28, 2019. https://doi.org/10.51684/FIRS.9842 (18.12.2021).
  42. Justin Morgenstern, "3 misunderstandings about WOMAN (TXA in postpartum hemorrhage)", First10EM blog, October 1, 2019. https://doi.org/10.51684/FIRS.9621rrhage)", First10EM blog, October 1, 2019. Available at https://doi.org/10.51684/FIRS.9621. (18.12.2021).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl